openPR Logo
Press release

BIS Research Study Highlights the Global Autoimmune Disorders Drug Delivery Devices Market to Reach $10,686.5 Million by 2030

11-24-2020 05:23 AM CET | Health & Medicine

Press release from: BIS Research

BIS Research Study Highlights the Global Autoimmune Disorders

The autoimmune disorders drug delivery devices market is projected to reach $10,686.5 million by 2030, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 15.25% during the period between 2020 and 2030.

The comprehensive study of global autoimmune disorders drug delivery devices by BIS Research extensively covers the following:

• Market numbers on micro-segments that are influencing the market
• More than 40 products present in the market
• Pricing data for more than 40 products
• Market share analysis
• Detailed global and regional market share analysis including the scrutiny of more than 10 countries
• Study of data of more than 40 companies

View the report from BIS Research at : https://bisresearch.com/industry-report/autoimmune-disorder-drug-delivery-devices-market.html

Besides these parameters, the study also encompasses the market growth drivers, opportunities, market restraining factors, competition mapping, and segmental analysis.

BIS Research study indicates that the increasing prevalence of autoimmune disorders, rise in the geriatric population, increasing research funding for research and development in the field of autoimmune disorders, increase in demand for biologics, and rising adoption of self-injectable systems are fueling the growth of the market.

The study highlights the various emerging opportunities, such as the development of novel autoimmune disorders drug delivery devices and massive scope for adoption of autoimmune disorder drug delivery devices in untapped areas that can be leveraged by players operating in the market.

Data from different segments of the market has been analyzed minutely to gain a holistic view of the market. These segments include product type, drug class, route of administration, indications, and regions. Each of these segments is further categorized into sub-segments and micro-segments to compile an in-depth study.

To emphasize the dominance of the rheumatoid arthritis segment over other segments under the product category of autoimmune disorder drug delivery devices market in 2019 and 2030, Shubham Mehta, Research Analyst – BIS Research, states, "The reason for market growth and the dominance of the rheumatoid arthritis segment can be attributed to the rising prevalence of rheumatoid arthritis, extensive product portfolio for the treatment of rheumatoid arthritis, and rising adoption of self-injection systems. It is anticipated that the entry of biosimilars will drive the growth of this segment in the coming years.”

Request for a Sample: https://bisresearch.com/requestsample?id=849&type=download

Key insights are drawn from in-depth interviews with the key opinion leaders of more than 20 leading companies, market participants, and vendors. The key players profiled in the report include AbbVie Inc., Amgen Inc., F. Hoffmann- La Roche Ltd., Novartis AG, GlaxoSmithKline Plc, Bristol Myers Squibb Company, Biogen Inc., Merck KGaA, Bayer AG, Johnson & Johnson Services Inc., Teva Pharmaceutical Industries Ltd., Eli Lily and Company, Sanofi S.A., UCB Inc., and Takeda Pharmaceutical Company Limited, among others

The study also offers strategic recommendations that can help organizations track various products, trends, and technologies that are changing the dynamics of the market. The recommendations by BIS Research also offer bespoke research services to help organizations meet their objectives.

Who should buy this report?
• Manufacturers of Autoimmune Disorder Therapeutics
• Distributors of Autoimmune Disorder Therapeutics
• Suppliers of Autoimmune Disorder Therapeutics
• CROs of Autoimmune Disorder Therapeutics
• Injectable Drug Delivery Device Manufacturers
• Research and Academic Institutions

How can market intelligence on autoimmune disorder drug delivery devices add value to an organization’s decision-making process?
• Aids in product development
• Aids in analyzing the pipeline of products
• Helps in targeting a segment for launching a new product
• Offers go to market strategies for different product categories
• Supports in diversifying the product portfolio on the basis of untapped areas
• Helps in analyzing technological substitutes and compare the specification
• Helps in understanding the clinical landscape
• Helps to adjust the pricing of upcoming products
• Assists in exploring the newer indications
Insightful Questions Covered to Enable Companies Take Strategic Decisions

• What are the various autoimmune disorders drug delivery devices available in the market?
• What are emerging drug delivery devices for the treatment of autoimmune disorders?
• How does the pipeline for global autoimmune disorders drug delivery devices market look like?
• What is the current market size and future potential of these drug delivery devices?
• What are the major market drivers, challenges, and opportunities in the global autoimmune disorders drug delivery devices market?
• What is the patent landscape of this market?
• What will be the impact of COVID-19 on this market?
• What are the guidelines implemented by different government bodies to regulate the approval of autoimmune disorders drug delivery devices?
• What are the key technological developments on which the current industry leaders are spending a major share of their research and development (R&D) investments?
• Who are the leading players holding dominating shares in the global autoimmune disorders drug delivery devices market, currently?
• What are the key strategies incorporated by the players of global autoimmune disorders drug delivery devices market, to sustain the competition and retain their supremacy?
• What is the current revenue contribution of the global autoimmune disorders drug delivery devices market (by product type), and how would it evolve in the forecast period?
• What is the current revenue contribution of the global autoimmune disorders drug delivery devices market (by indication), and how would it evolve in the forecast period?
• What is the current revenue contribution of the global autoimmune disorders drug delivery devices market (by route of administration), and how would it evolve in the forecast period?
• What is the current revenue contribution of the global autoimmune disorders drug delivery devices market (by usage type), and how would it evolve in the forecast period?
• What is the current revenue contribution of the global autoimmune disorders drug delivery devices market (by therapeutics), and how would it evolve in the forecast period?
• Which region is expected to contribute to the highest revenue of the global autoimmune disorders drug delivery devices market during the forecast period?

Contact:
Bhavya Banga
Email: media@bisresearch.com
BIS Research Inc.
39111 PASEO PADRE PKWY STE 313,
FREMONT CA 94538-1686
Visit our Blog @ https://blog.bisresearch.com/
Connect with us on LinkedIn @ https://www.linkedin.com/company/bis-research
Connect with us on Twitter@ https://twitter.com/BISResearch

About BIS Research:

BIS Research is a global B2B market intelligence and advisory firm focusing on deep technology and related emerging trends which can disrupt the market dynamics in the near future. We publish more than 200 market intelligence studies annually that focus on several deep technology verticals.

Our strategic market analysis emphasizes on market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.

BIS Research offers syndicate as well as, custom studies, and expert consultations to firms, providing them specific and actionable insights on novel technology markets, business models, and competitive landscape.

BIS Healthcare vertical offers intelligence in the healthcare technology market for Medical Devices, Digital Health, Life Sciences, Robotics and Imaging, Information Technology, Precision Medicine, and other emerging healthcare technologies, covering the entire industry spectrum. In the past 5 years, BIS Healthcare has published more than 50 reports under the precision medicine banner. Additionally, BIS Research has been nominating Top 25 Voices in Precision Medicine on its Insight Monk platform for the past two years successfully.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release BIS Research Study Highlights the Global Autoimmune Disorders Drug Delivery Devices Market to Reach $10,686.5 Million by 2030 here

News-ID: 2193880 • Views:

More Releases from BIS Research

Explore the White Natural Hydrogen Market is estimated to reach 115.09 Million Tons by 2033
Explore the White Natural Hydrogen Market is estimated to reach 115.09 Million T …
The term "white natural hydrogen" might sound like something out of science fiction, White hydrogen is not produced using environmentally harmful methods or renewable electricity; instead, it is directly sourced from the Earth's natural geological resources. This abundant form of hydrogen, prevalent within the Earth's crust, serves as an endless and eco-friendly energy source. While challenges persist regarding its extraction and infrastructure development, the growing clean energy sector and rising
High-Altitude Aeronautical Platform Station Market 2023-2033: Opportunity, Competitive Landscape, Regional Demand and Major Players
High-Altitude Aeronautical Platform Station Market 2023-2033: Opportunity, Compe …
The aerospace industry is witnessing a surge in interest and development in High-Altitude Aeronautical Platform Stations (HAAPS). These platforms, situated in the Earth's stratosphere, offer a plethora of capabilities ranging from telecommunications to surveillance and even environmental monitoring. The HAAPS market is poised for exponential growth as various industries recognize the immense potential these platforms hold in transforming connectivity and data gathering on a global scale. Read Report Overview: https://bisresearch.com/industry-report/high-altitude-aeronautical-platform-station-market.html The global
Electric Vehicle Market Analysis, Share, Leading Key Players & Industry Overview | BIS Research
Electric Vehicle Market Analysis, Share, Leading Key Players & Industry Overview …
In recent years, the automotive landscape has witnessed a remarkable transformation propelled by the advent of Electric Vehicles (EVs). This paradigm shift from traditional internal combustion engine (ICE) vehicles to electric-powered cars has ignited an electrifying revolution in the industry. The global push towards sustainability, coupled with technological advancements and changing consumer preferences, has set the stage for the burgeoning growth of the Electric Vehicle market. Get Detailed insights: https://bisresearch.com/industry-verticals/automotive The Rise
EV Charging Communication Unit Market Share, Revenue, Key Players and Forecast 2023-2032
EV Charging Communication Unit Market Share, Revenue, Key Players and Forecast 2 …
The EV Charging Communication Unit Market refers to the industry involved in producing and supplying communication units essential for electric vehicle (EV) charging infrastructure. These units facilitate communication between EVs and charging stations, enabling data exchange for monitoring, authentication, billing, and control functions. The market encompasses various technologies and protocols, ensuring interoperability and efficient charging operations across different EV models and charging networks. It is a pivotal segment within the

All 4 Releases


More Releases for Autoimmune

Autoimmune Disease Diagnostics Market - Forecast to 2026
The findings reviewed by GME stated that the Global Autoimmune Disease Diagnostics Market would grow at a CAGR value of 8.9 percent from 2021 to 2026. Today, the advancing technology & automation, increasing awareness about risks and implications of autoimmune disease if left undiagnosed & untreated, and the awareness about the benefits of various diagnostics available are accelerating growth in the market. Also, there has been an exponential increase
The Autoimmune Registry releases first complete list of autoimmune diseases with …
The Autoimmune Registry Inc (ARI) has published its first comprehensive List of Autoimmune Diseases: https://www.autoimmuneregistry.org/autoimmune-diseases. It includes over 150 diseases, 40 subtypes, and 60 synonyms. ARI created the list to provide patients and researchers easy access to the latest literature and information about autoimmune disease. ARI’s list is searchable and filterable, with links to peer-reviewed research, patient groups, and other resources. Between 15 and 30 million people in
Autoimmune Disease Diagnostics Market: Growing Awareness among People about Auto …
According to the recent report by Transparency Market Research, the global autoimmune disease diagnostics market has a highly consolidated scenario. The market is dominated by a handful of players. However, these players have a stronghold over the dynamics of market and pose a great challenge for any new entrant to set its foot in the market. Read Report Overview - https://www.transparencymarketresearch.com/autoimmune-disease-diagnostics-market.html To reduce effects of such hindrances, the new entrants are
Autoimmune Disease Therapeutics Market Boost due to increase in incidence of aut …
According to a new report published by Allied Market Research, titled,"Autoimmune Disease Therapeutics Market by Drug Class, Indication, and Sales Channel: Global Opportunity Analysis and Industry Forecast, 2018 - 2025," the global autoimmune disease therapeutics market was valued at $109,833 million in 2017, and is expected to reach $153,320 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025. Download the Sample Report @ https://www.alliedmarketresearch.com/request-sample/5185?utm_source=openpr&utm_medium=Niranjan Autoimmune disease therapeutics include
Autoimmune Treatment Market North America Leads the Global Autoimmune Treatment …
The global autoimmune treatment market is growing significantly due to increasing incidences of autoimmune diseases, up surging healthcare expenditure, and advancements in the technologies for the development of autoimmune diseases therapeutics. Autoimmune diseases are chronic in nature and do not have permanent treatment. This creates ample growth opportunity for the autoimmune treatment market, to grow at a considerable rate in the coming years. The advanced research and development facilities, and
Autoimmune Disease Diagnostics Market: Rise in Autoimmune Diseases, alongside Gr …
Global Autoimmune Disease Diagnostics Market: Snapshot The global autoimmune disease diagnostics market is expected to witness a modest growth in the coming years on account of the growing incidences of autoimmune diseases among people worldwide. Efficient autoimmune disease diagnostics has become absolutely essential to tackle this issue. Governments across nations are also increasing their spending towards healthcare in light of these growing incidences of autoimmune diseases. This has also resulted in